The transcription factor Nurr1 has been implicated in Parkinson disease (PD)—a movement disorder caused by selective destruction of dopaminergic neurons. Researchers have now shown that targeted ablation of Nurr1 in dopaminergic neurons in adult mice recapitulates early features of PD, including motor impairment. Next-generation RNA sequencing of these neurons revealed that mitochondrial genes are a key regulatory target of Nurr1, in line with the known involvement of mitochondrial dysfunction in PD. Together, the findings suggest Nurr1 as a potential therapeutic target in PD.